ABSTRACT
Endometrial carcinoma has been the most common female pelvic malignancy in the U.S.A. Approximately one-fourth of patient treated for early endometrial cancer will develop reccure-nt disease. Kelly and Baker first descibed that the use of progestational agents for treatment of met- astatic endometrial cancer in 1961. Response of progesterone therapy in metastatic endometrial cancer is related to several factors. Higher response rates are observed in well differentiated tumors, longer disease free interval and tumors that positive for estrogen and progesterone re- ceptors. We experienced a case of complete response in recurrent endometrial cancer to metastasis to lung treated by tamoxifen and progesterone, we present this case with a brief review of lite- rature.
Subject(s)
Female , Humans , Endometrial Neoplasms , Estrogens , Lung , Neoplasm Metastasis , Progesterone , Progestins , TamoxifenABSTRACT
Endodermal sinus tumors(EST) have also been referred to as "yolk sac tumors" because they are derived from the primitive yolk sac. These lesions are the third most frequent malignant germ-cell tumors of the ovary. Recent advances in treating the endodermal sinus tumor of the ovary with the combination chemotherapy result in improvement of the prognosis. We had experienced a case of the endodermal sinus tumor of 15 year old woman. We report this case with a brief review of literatures.
Subject(s)
Adolescent , Female , Humans , Drug Therapy, Combination , Endoderm , Endodermal Sinus Tumor , Ovary , Prognosis , Yolk SacABSTRACT
No abstract available.
Subject(s)
Nucleolus Organizer Region , Proliferating Cell Nuclear AntigenABSTRACT
No abstract available.
Subject(s)
Nucleolus Organizer Region , Proliferating Cell Nuclear AntigenABSTRACT
No abstract available.